Therapy for fracture prevention.
- 18 August 1999
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 282 (7) , 687-689
- https://doi.org/10.1001/jama.282.7.687
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Vertebral Fractures and Mortality in Older WomenArchives of internal medicine (1960), 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- THE ROLE OF ESTROGEN IN THE PREVENTION OF OSTEOPOROSISEndocrinology and Metabolism Clinics of North America, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Correcting calcium nutritional deficiency prevents spine fractures in elderly womenJournal of Bone and Mineral Research, 1996
- Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in WomenAnnals of Internal Medicine, 1991
- Acute Atrophy of Bone (Osteoporosis) Simulating Hyperparathyroidism12Journal of Clinical Endocrinology & Metabolism, 1941